1
Considerable evidence suggests that immune competence is important in the control of cutaneous SCC.
2
Immune suppressed organ transplant recipients suffer increased morbidity and mortality from primary cutaneous SCC.
3
One month after the amputation, local recurrence of cutaneous SCC and multiple lung metastases were observed.
4
No definitive, comprehensive clinicopathological system dividing cutaneous SCCs into categories based upon their aggressiveness has yet been promulgated.
5
Our study shows that despite their similar origins, human cutaneous SCCs and BCCs are considerably different in their TAMs.
6
Further and larger prospective studies are needed to clarify the role of HPV in the aetiology of cutaneous SCC.
7
The aim of this study was to prospectively analyse the key factors predicting metastasis and local recurrence in cutaneous SCC.
8
We present the first case report of a male patient with HHM with leukocytosis caused by cutaneous SCC resulting from RDEB.
9
Exclusion criteria were a history of cutaneous SCC of head and neck or extension of primary tumor into the parotid gland.
10
Conclusions: Smoking-associated risks for cutaneous SCC and BCC are in the opposite direction to each other and appear to vary by anatomical site.